NCT00662883View on ClinicalTrials.gov

Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

PMI-150 (intranasal ketamine HCl); mometasone furoate

"* 1 dose PMI-150 (intranasal ketamine HCl); day 1~* mometasone furoate, daily; days 2-15~* 1 dose PMI-150 (intranasal ketamine HCl); day 15"

Trial Locations (1)

21225

Baltimore

Sponsors
All Listed Sponsors
lead

Javelin Pharmaceuticals

INDUSTRY